NCT06610552

Brief Summary

The goal of this clinical trial is to determine if the Powerly app can help prevent postpartum depression and anxiety in healthy pregnant women. The main questions it aims to answer are:

  • Does the Powerly app reduce postpartum depression and anxiety?
  • Does it improve emotion regulation and maternal bonding with a child? Researchers will compare two groups: one using the Powerly app and the other receiving care as usual (CAU) to see if the app leads to better mental health outcomes. Participants will:
  • Use the Powerly app for four weeks (if in the intervention group).
  • Complete mental health assessments before the study, after four weeks, and six weeks postpartum.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Feb 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Feb 2024Oct 2026

Study Start

First participant enrolled

February 1, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 20, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 24, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2026

Last Updated

May 20, 2025

Status Verified

May 1, 2025

Enrollment Period

2.7 years

First QC Date

September 20, 2024

Last Update Submit

May 15, 2025

Conditions

Keywords

pregnancypostpartum depressionpostpartum anxietystressdigital healthmobile healthecological momentary intervention

Outcome Measures

Primary Outcomes (2)

  • DASS (Depression, Anxiety, and Stress Scales)

    a validated set of brief scales consisting of 21 items used to measure the severity of depression, anxiety, and stress symptoms

    From baseline measurement until the second follow-up measurement at 6 weeks postpartum

  • PDSS (Postpartum Depression Screening Scale)

    a comprehensive tool comprising 35 items designed to identify symptoms of postpartum depression, including aspects such as sleep and eating disturbances, insecurity, emotional lability, guilt, and shame

    Collected only at second follow-up measurement 6 weeks postpartum

Secondary Outcomes (10)

  • CERQ (Cognitive Emotion Regulation Questionnaire)

    From baseline measurement until the second follow-up measurement at 6 weeks postpartum

  • PASS-C (Positive Appraisal Style scale - content)

    From baseline measurement until the second follow-up measurement at 6 weeks postpartum

  • BRS (Brief Resilience Scale)

    From baseline measurement until the second follow-up measurement at 6 weeks postpartum

  • BSS-RI (Birth Satisfaction Scale - Revised Indicator)

    Collected only at second follow-up measurement 6 weeks postpartum

  • PBQ (Postpartum Bonding Scale)

    Collected only at second follow-up measurement 6 weeks postpartum

  • +5 more secondary outcomes

Other Outcomes (2)

  • BFI-10 (Big Five Inventory-10)

    Collected only during baseline measurement

  • PMH (Positive Mental Health scale)

    Collected only during baseline measurement

Study Arms (2)

Intervention - Powerly

EXPERIMENTAL

Participants in the intervention group will complete baseline questionnaires and receive instructions on how to download Powerly. They will use the app daily for 28 days, at least once per day, and will be invited to complete the questionnaires again, and once more six weeks postpartum.

Behavioral: Powerly

Care as usual

NO INTERVENTION

Participants in the CAU group will complete baseline questionnaires and be informed that they will receive access to Powerly six weeks postpartum. They will be invited to complete the questionnaires again 28 days later, and once more six weeks postpartum.

Interventions

PowerlyBEHAVIORAL

Powerly is a mental well-being mobile app, in which pregnant women can track their mood and level of stress, and receive personalized psychological modules to increase their mental health and well-being. By integrating evidence-based content and cognitive behavioral techniques with insights from pregnant and postpartum individuals and health professionals, Powerly offers a comprehensive psychological support including reappraisal, mental imagery, gratitude, mindfulness, self-efficacy and behavioral activation exercises.

Intervention - Powerly

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • being between 24 and 32 weeks pregnant,
  • owning an iPhone,
  • having sufficient fluency in German language

You may not qualify if:

  • high-risk pregnancies,
  • history of substance abuse and psychiatric disorders such as bipolar disorder, schizophrenia, or other psychotic disorders,
  • current use of professional face-to-face psychotherapeutic support,
  • participation in other clinical trials or interventions at the same time

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Zurich

Zurich, Switzerland

RECRUITING

Related Publications (1)

  • Marciniak MA, Rohde J, Yuen KSL, Binder H, Walter H, Wieser MJ, Kalisch R, Roelofs K, Kleim B. Development of Powerly, unguided mobile app intervention preventing postpartum depression and anxiety & study protocol of randomized clinical trial. Internet Interv. 2025 Jun 16;41:100843. doi: 10.1016/j.invent.2025.100843. eCollection 2025 Sep.

MeSH Terms

Conditions

Depression, Postpartum

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Central Study Contacts

Marta A. Marciniak, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

September 20, 2024

First Posted

September 24, 2024

Study Start

February 1, 2024

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

October 30, 2026

Last Updated

May 20, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

Anonymized questionnaire (self-report) data will be shared in an open science repository, for instance Open Science Framework.

Shared Documents
STUDY PROTOCOL
Time Frame
The data will be shared after the study completion (published along with manuscripts from the trial), without the end date.
Access Criteria
The data will be publicly available.

Locations